Aquestive Therapeutics, Inc. · NASDAQ:AQST
Aquestive Therapeutics, Inc. shareholders
As of Sep 30, 2026, 186 institutions reported holding Aquestive Therapeutics, Inc., 60.1% of its shares. Largest: Bratton Capital Management, L.P., BlackRock and Rtw Investments, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aquestive Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Bratton Capital Management, L.P. | 9.81M | 7.8% | no change | Nov 3, 2026 |
| BlackRock | 8.21M | 6.5% | +144K | Nov 13, 2026 |
| Rtw Investments, LP | 7.43M | 5.9% | no change | Nov 16, 2026 |
| Vanguard | 6.33M | 5.0% | +322K | Nov 13, 2026 |
| State Street | 3.48M | 2.8% | +553K | Nov 12, 2026 |
| Federated Hermes, Inc. | 3.2M | 2.5% | +85,300 | Nov 12, 2026 |
| Geode Capital | 2.9M | 2.3% | +273K | Nov 6, 2026 |
| Samsara Biocapital, LLC | 2.43M | 1.9% | −65,633 | Nov 16, 2026 |
| Rosalind Advisors, Inc. | 2M | 1.6% | +1.75M | Nov 16, 2026 |
| Hrt Financial LP | 1.8M | 1.4% | +1.46M | Nov 13, 2026 |